Epidemiological burden of postmenopausal osteoporosis in France from 2010 to 2020: estimations from a disease model

Epidemiological burden of postmenopausal osteoporosis in France from 2010 to 2020: estimations from a disease model

Taispeáin leaganacha eile (1)

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Cawston, H, Maravic, M, Fardellone, P, Gauthier, A, Kanis, J, Compston, J, Borgström, F, Cooper, C, McCloskey, E
Formáid:	Journal article
Foilsithe / Cruthaithe:	2012

Míreanna comhchosúla

Epidemiological burden of postmenopausal osteoporosis in France from 2010 to 2020: estimations from a disease model.
de réir: Cawston, H, et al.
Foilsithe / Cruthaithe: (2012)

Epidemiological burden of postmenopausal osteoporosis in the UK from 2010 to 2021: estimations from a disease model.
de réir: Gauthier, A, et al.
Foilsithe / Cruthaithe: (2011)

Burden of postmenopausal osteoporosis in Germany: estimations from a disease model
de réir: Gauthier, A, et al.
Foilsithe / Cruthaithe: (2012)

Burden of postmenopausal osteoporosis in Germany: estimations from a disease model.
de réir: Gauthier, A, et al.
Foilsithe / Cruthaithe: (2012)

Development and validation of a disease model for postmenopausal osteoporosis.
de réir: Gauthier, A, et al.
Foilsithe / Cruthaithe: (2011)

DEVELOPMENT AND VALIDATION OF AN EPIDEMIOLOGICAL MODEL TO ESTIMATE THE BURDEN OF POST-MENOPAUSAL OSTEOPOROSIS
de réir: Gauthier, A, et al.
Foilsithe / Cruthaithe: (2010)

Development and validation of a disease model for postmenopausal osteoporosis.
de réir: Gauthier, A, et al.
Foilsithe / Cruthaithe: (2011)

DEVELOPMENT AND VALIDATION OF A DISEASE MODEL FOR POSTMENOPAUSAL OSTEOPOROSIS
de réir: Gauthier, A, et al.
Foilsithe / Cruthaithe: (2009)

Osteoporosis: burden, health care provision and opportunities in the EU: a report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA).
de réir: Ström, O, et al.
Foilsithe / Cruthaithe: (2011)

European guidance for the diagnosis and management of osteoporosis in postmenopausal women.
de réir: Kanis, J, et al.
Foilsithe / Cruthaithe: (2013)

Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update 2013.
de réir: Compston, J, et al.
Foilsithe / Cruthaithe: (2013)

Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update 2013 (vol 75, pg 392, 2013)
de réir: Compston, J, et al.
Foilsithe / Cruthaithe: (2013)

Erratum: Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update 2013 (Maturitas (2013) 75 (392-396))
de réir: Compston, J, et al.
Foilsithe / Cruthaithe: (2013)

Erratum: Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update 2013 (Maturitas (2013) 75 (392-396))
de réir: Compston, J, et al.
Foilsithe / Cruthaithe: (2014)

THE ECONOMIC BURDEN OF FRACTURES IN THE EUROPEAN UNION IN 2010
de réir: Kanis, J, et al.
Foilsithe / Cruthaithe: (2012)

European guidance for the diagnosis and management of osteoporosis in postmenopausal women.
de réir: Kanis, J, et al.
Foilsithe / Cruthaithe: (2008)

European guidance for the diagnosis and management of osteoporosis in postmenopausal women (Osteoporosis International DOI: 10.1007/s00198-008-0560-z)
de réir: Kanis, J, et al.
Foilsithe / Cruthaithe: (2008)

Modelling cost-effectiveness in osteoporosis
de réir: Kanis, J, et al.
Foilsithe / Cruthaithe: (2008)

European guidance for the diagnosis and management of osteoporosis in postmenopausal women (vol 19, pg 399, 2008)
de réir: Kanis, J, et al.
Foilsithe / Cruthaithe: (2008)

The cost-effectiveness of alendronate in the management of osteoporosis.
de réir: Kanis, J, et al.
Foilsithe / Cruthaithe: (2008)

Baseline clinical characteristics of postmenopausal women with osteoporosis and an inadequate clinical response to osteoporosis drugs in the observational study of severe osteoporosis (OSSO).
de réir: Sykes, D, et al.
Foilsithe / Cruthaithe: (2005)

Long-term treatment of osteoporosis in postmenopausal women: a review from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF).
de réir: Cooper, C, et al.
Foilsithe / Cruthaithe: (2012)

Glucocorticoid-induced osteoporosis: a systematic review and cost-utility analysis
de réir: J Kanis, et al.
Foilsithe / Cruthaithe: (2007-03-01)

The US FRAX filter: avoiding confusion or hindering progress?
de réir: McCloskey, E, et al.
Foilsithe / Cruthaithe: (2010)

The US FRAX® filter: avoiding confusion or hindering progress?
de réir: McCloskey, E, et al.
Foilsithe / Cruthaithe: (2010)

Adverse reactions and drug-drug interactions in the management of women with postmenopausal osteoporosis.
de réir: Rizzoli, R, et al.
Foilsithe / Cruthaithe: (2011)

REASONS FOR STOPPING ANTI-OSTEOPOROSIS MEDICATIONS AMONG POSTMENOPAUSAL WOMEN: THE GLOBAL LONGITUDINAL STUDY OF OSTEOPOROSIS IN WOMEN
de réir: Hooven, F, et al.
Foilsithe / Cruthaithe: (2010)

Joint Official Positions of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX(®). Executive Summary of the 2010 Position Development Conference on Interpretation and use of FRAX® in clinical practice.
de réir: Hans, D, et al.
Foilsithe / Cruthaithe: (2011)

Joint Official Positions of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX®. Executive Summary of the 2010 Position Development Conference on Interpretation and Use of FRAX® in Clinical Practice
de réir: Hans, D, et al.
Foilsithe / Cruthaithe: (2011)

Burden of non-hip, non-vertebral fractures on quality of life in postmenopausal women: the Global Longitudinal study of Osteoporosis in Women (GLOW).
de réir: Roux, C, et al.
Foilsithe / Cruthaithe: (2012)

Treatment of patients with postmenopausal osteoporosis is worthwhile. The position of the International Osteoporosis Foundation.
de réir: Delmas, P, et al.
Foilsithe / Cruthaithe: (2005)

Treatment of osteoporosis in men.
de réir: Kaufman, J, et al.
Foilsithe / Cruthaithe: (2013)

Is it time to consider population screening for fracture risk in postmenopausal women? A position paper from the International Osteoporosis Foundation Epidemiology/Quality of Life Working Group
de réir: Chotiyarnwong, P, et al.
Foilsithe / Cruthaithe: (2022)

Stefano Fenoaltea (1943-2020)
de réir: Deirdre McCloskey
Foilsithe / Cruthaithe: (2021-01-01)

Fracture risk following intermission of osteoporosis therapy
de réir: Dennison, EM, et al.
Foilsithe / Cruthaithe: (2019)

Disease Burden and Treatment Preferences Amongst Postmenopausal Women with Severe Osteoporosis in Greece
de réir: Souliotis K, et al.
Foilsithe / Cruthaithe: (2023-01-01)

Vitamin D supplementation in elderly or postmenopausal women: a 2013 update of the 2008 recommendations from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO).
de réir: Rizzoli, R, et al.
Foilsithe / Cruthaithe: (2013)

Osteoporosis in postmenopausal women
de réir: Harvey, M, et al.
Foilsithe / Cruthaithe: (2002)

BREASTFEEDING AND POSTMENOPAUSAL OSTEOPOROSIS
de réir: Horia Lăzărescu, et al.
Foilsithe / Cruthaithe: (2019-09-01)

Hypercalciuria in Postmenopausal Osteoporosis
de réir: Ayfer Kanberoğlu, et al.
Foilsithe / Cruthaithe: (2004-06-01)